✦ LIBER ✦

Baclofen for Alcohol Dependence: A Preliminary Open-Label Study

✍ Scribed by Barbara A. Flannery; James C. Garbutt; Meghan W. Cody; William Renn; Kathy Grace; Michael Osborne; Ken Crosby; Mary Morreale; Amy Trivette

Book ID: 110086752
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 304 KB
Volume: 28
Category: Article
ISSN: 0145-6008
DOI: 10.1097/01.alc.0000141640.48924.14

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mirtazapine for patients with alcohol de

Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: A multicentre, open label study

✍ Su-Jung Yoon; Chi-Un Pae; Dai-Jin Kim; Kee Namkoong; Eun Lee; Dong-Yul Oh; Young 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Varenicline for tobacco dependence treat

Varenicline for tobacco dependence treatment in recovering alcohol-dependent smokers: An open-label pilot study

✍ J. Taylor Hays; Ivana T. Croghan; Darrell R. Schroeder; Jon O. Ebbert; Richard D 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 120 KB

A prospective, open-label trial of ondan

A prospective, open-label trial of ondansetron in adolescents with alcohol dependence

✍ Michael A. Dawes; Bankole A. Johnson; Nassima Ait-Daoud; Jennie Z. Ma; Jack R. C 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Baclofen: a new drug for the treatment o

Baclofen: a new drug for the treatment of alcohol dependence

✍ G. ADDOLORATO; L. LEGGIO; R. AGABIO; G. COLOMBO; G. GASBARRINI 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

Open-label nefazodone in patients with a

Open-label nefazodone in patients with a major depressive episode and alcohol dependence

✍ E.Sherwood Brown; Leonardo Bobadilla; Vicki A. Nejtek; Dana Perantie; Harminder 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Safety, tolerability, and feasibility of

Safety, tolerability, and feasibility of high-dose naltrexone in alcohol dependence: an open-label study

✍ Gihyun Yoon; Suck Won Kim; Paul Thuras; Joseph Westermeyer 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Objective Prior trials testing standard-dose naltrexone (50 mg/day) have generated mixed results in the treatment of alcohol dependence. The purpose of this study was to evaluate the short-term safety, tolerability, and feasibility of high-dose naltrexone (150 mg/day) for treating alcohol-dependent